The third mechanism of action is the activation of the c-cells on the thyroid that communicate with the beta-cells of the pancreas to release more insulin. This medication does not make us necessarily create more insulin than we already do, creating a baseline; however, it allows for more of the insulin to be pushed out of the pancreas to allow us to have better control of our blood glucose levels. When we have better control of our blood glucose levels, the body’s metabolism is able to focus on burning excess body weight after it breaks down our daily food intake. 

This class of GLP-1 medications has been FDA-approved for both diabetes and weight loss in those with a body mass index (BMI) over 27. It has been shown to reduce weight, decrease insulin and blood sugar spikes, improve cholesterol, improve blood pressure, improve side effects of inflammatory diseases, decrease overall heart attack and stroke risk, improve non-alcoholic fatty liver, and improve hormonal imbalances. 

Semaglutide and Tirzepatide are both once-a-week subcutaneous injections administered by our staff in the office or by yourself into the arm, thigh, or abdomen.